WO2022077853A1 - Method for extracting grifola frondosa active polysaccharide, and extracted active polysaccharide and use thereof - Google Patents
Method for extracting grifola frondosa active polysaccharide, and extracted active polysaccharide and use thereof Download PDFInfo
- Publication number
- WO2022077853A1 WO2022077853A1 PCT/CN2021/080132 CN2021080132W WO2022077853A1 WO 2022077853 A1 WO2022077853 A1 WO 2022077853A1 CN 2021080132 W CN2021080132 W CN 2021080132W WO 2022077853 A1 WO2022077853 A1 WO 2022077853A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ultrafiltration
- grifola frondosa
- permeate
- extract
- microfiltration
- Prior art date
Links
- 240000001080 Grifola frondosa Species 0.000 title claims abstract description 89
- 235000007710 Grifola frondosa Nutrition 0.000 title claims abstract description 89
- 150000004676 glycans Chemical class 0.000 title claims abstract description 71
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 71
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 71
- 238000000034 method Methods 0.000 title claims abstract description 30
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 78
- 239000012528 membrane Substances 0.000 claims abstract description 56
- 239000000284 extract Substances 0.000 claims abstract description 54
- 238000001471 micro-filtration Methods 0.000 claims abstract description 51
- 239000012466 permeate Substances 0.000 claims abstract description 51
- 239000012465 retentate Substances 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 239000012141 concentrate Substances 0.000 claims abstract description 14
- 238000001035 drying Methods 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000000605 extraction Methods 0.000 claims description 37
- 239000011148 porous material Substances 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 20
- 239000007787 solid Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 239000000919 ceramic Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 229920000620 organic polymer Polymers 0.000 claims description 4
- 230000000717 retained effect Effects 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 230000008569 process Effects 0.000 abstract description 5
- 238000005374 membrane filtration Methods 0.000 abstract description 3
- 238000004094 preconcentration Methods 0.000 abstract description 3
- 230000002829 reductive effect Effects 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000002035 prolonged effect Effects 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 17
- 239000008103 glucose Substances 0.000 description 17
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 241000700159 Rattus Species 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000009826 distribution Methods 0.000 description 6
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 4
- 238000010171 animal model Methods 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 150000002772 monosaccharides Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000222684 Grifola Species 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 241000233866 Fungi Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 208000018914 glucose metabolism disease Diseases 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 235000021070 high sugar diet Nutrition 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 229960004329 metformin hydrochloride Drugs 0.000 description 1
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- -1 small molecule monosaccharide Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
Definitions
- the invention relates to a method for extracting polysaccharide, in particular to a method for extracting active polysaccharide from Grifola frondosa based on membrane filtration technology, and the active polysaccharide from Grifola frondosa extracted by the method and its application.
- Grifola frondosa is a traditional edible and medicinal fungus in my country, which has good health care function and high medicinal value. Research results at home and abroad show that Grifola has the effects of reducing insulin resistance, controlling blood sugar, inhibiting the accumulation of fat cells, lowering blood pressure, enhancing immunity and anti-cancer.
- Grifola frondosa polysaccharide is an extract from Grifola frondosa. It is composed of glucan, small molecule monosaccharide and a small amount of protein heterosaccharide complexes. Animal experiments and clinical experiments have shown that it can activate phagocytes, induce Apoptosis of cancer cells to play anti-cancer and anti-cancer effects.
- the extraction and preparation of Grifola frondosa polysaccharides generally adopts water extraction and alcohol precipitation.
- ethanol is added to remove water-soluble small molecular impurities such as water-soluble proteins and monosaccharides, and crude polysaccharides are precipitated.
- the purification efficiency of alcohol precipitation is low, the composition in the precipitate is complex, the polysaccharide content is reduced, the efficacy and activity is affected, and the amount of ethanol used is large, resulting in high polysaccharide preparation and production cost, and causing a certain degree of environmental pollution.
- the present invention provides a method for extracting Grifola frondosa active polysaccharide based on membrane filtration technology, which can greatly simplify the preparation process of Grifola frondosa polysaccharide, the extracted polysaccharide has high purity, and the extraction is performed in reverse according to the effect of the active polysaccharide. Screening of method parameters, such as ultrafiltration parameters, can make the extracted active polysaccharide have a significant effect, and also realize the industrial application of the extraction method.
- the present invention achieves the above object through the following schemes:
- a first aspect a method for extracting active polysaccharide from Grifola frondosa, comprising:
- Microfiltration pretreatment is carried out on the extract of Grifola frondosa, the pore size of the microfiltration membrane is 100-400nm, the temperature is controlled at 25-60°C, and the operating pressure is within 1MPa, the microfiltration permeate is collected, and the microfiltration unpermeable liquid is discarded. liquid;
- the microfiltration permeate is subjected to ultrafiltration treatment.
- the pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 1-18KDa, the operating pressure is 0.3-1MPa, and the temperature is controlled at 25-40°C.
- the volume of the permeate is 40% of the total volume Stop the ultrafiltration when -75%, keep the ultrafiltration retentate that does not permeate the membrane, and discard the ultrafiltration permeate;
- the obtained dry powder is the Grifola frondosa polysaccharide.
- the invention further optimizes the parameters of the above extraction method to obtain a method with higher extraction efficiency and better purity: a method for extracting active polysaccharide from Grifola frondosa, comprising:
- Microfiltration pretreatment is carried out on the extract of Grifola frondosa, the pore size of the microfiltration membrane is 100-200 nm, the temperature is controlled at 25-55 °C, and the operating pressure is within 0.8 MPa, the microfiltration permeate is collected, and the microfiltration unfiltered liquid is discarded. permeate;
- the microfiltration permeate is subjected to ultrafiltration treatment, the pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 2-15KDa, the operating pressure is 0.3-0.6MPa, and the temperature is controlled at 25-35°C.
- the volume of the permeate is 55% of the total volume %-75%, stop the ultrafiltration, keep the ultrafiltration retentate that does not pass through the membrane, and discard the ultrafiltration permeate;
- the obtained dry powder is the Grifola frondosa polysaccharide.
- the separation process is equivalent to one-time pre-concentration, and then the microfiltration and ultrafiltration technologies are used in combination, which has the advantages of simple operation, low energy consumption, short production cycle, the filter membrane can be used multiple times, and the whole process of filtration is low temperature. There is no solvent residue in the operation, which can prevent the destruction of the active components in the Grifola frondosa extract to the greatest extent.
- the inventor continuously adjusted the laboratory-scale extraction method to obtain an industrialized extraction method for Grifola frondosa active polysaccharide, including:
- the microfiltration permeate is introduced into the ultrafiltration equipment, and the polysaccharides of different molecular weights are intercepted and purified with an ultrafiltration membrane.
- the pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 1-18KDa, the operating pressure is 0.3-1MPa, and the temperature is controlled at 25-40 °C, when the volume of the permeate is controlled at 40%-75% of the total volume, the ultrafiltration is stopped, the ultrafiltration retentate that does not permeate the membrane is retained, and the ultrafiltration permeate is discarded;
- the obtained dry powder is the finished product of Grifola frondosa polysaccharide.
- the inventor has successfully optimized the extraction method of the industrialized Grifola frondosa active polysaccharide in the laboratory-scale extraction method in combination with the above-mentioned research on extraction efficiency and purity, including:
- the microfiltration membrane pore size is 100-200nm, the temperature is controlled at 25-55°C, and the operating pressure is within 0.8MPa, the microfiltration permeate is collected, and the microfiltration permeate is discarded. Filter the permeate;
- the microfiltration permeate is introduced into the ultrafiltration equipment, and the polysaccharides of different molecular weights are intercepted and purified by the ultrafiltration membrane.
- the pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 2-15KDa, the operating pressure is 0.3-0.6MPa, and the temperature is controlled at 25-35 °C, when the volume of the permeate is controlled at 55%-75% of the total volume, the ultrafiltration is stopped, the ultrafiltration retentate that does not permeate the membrane is retained, and the ultrafiltration permeate is discarded;
- the obtained dry powder is the finished product of Grifola frondosa polysaccharide.
- the drying of the ultrafiltration retentate includes: one or more of spray drying, freeze drying, vacuum drying or normal pressure drying.
- the microfiltration membrane material is one or more of ceramic membranes, organic polymer membranes, and metal membranes.
- the pore size of the ultrafiltration membrane is less than 100 nm, the molecular weight cutoff is in the range of 1-18KDa, and the ultrafiltration membrane material is one or more of ceramic membranes, organic polymer membranes, and metal membranes.
- the microfiltration operation belongs to a physical extraction liquid pretreatment method, and similar pretreatments such as vacuum filtration, activated carbon decolorization, low-speed centrifugation, and high-speed centrifugation can also be used. method; however, the inventor found that the combination of microfiltration and ultrafiltration is more conducive to the extraction of Grifola frondosa active polysaccharide and the life of the ultrafiltration membrane, and the extraction cost is saved.
- the second method, the present invention provides a Grifola frondosa polysaccharide extracted by the above extraction method.
- the molecular weight distribution of the Grifola frondosa active polysaccharide is more concentrated and the purity is higher.
- the present invention provides the use of the Grifola frondosa active polysaccharide obtained by the above extraction in hypoglycemic.
- the present invention provides the use of the Grifola frondosa active polysaccharide obtained by the above extraction in preparing a hypoglycemic drug.
- the present invention has the following beneficial effects:
- microfiltration and ultrafiltration technology has the advantages of simple operation, low energy consumption, short production cycle, and the filter membrane can be used multiple times. Active ingredients, while the separation process is equivalent to a pre-concentration;
- the extraction solution is treated by microfiltration before ultrafiltration to remove larger suspended particles or colloidal substances in the extraction solution, thereby improving the ultrafiltration effect, reducing membrane pollution, helping to improve production efficiency and prolonging the service life of ultrafiltration membranes ,cut costs;
- the method of the present invention is suitable for industrialization and has good economic prospects.
- the Grifola frondosa polysaccharide extracted by the present invention has higher purity, more concentrated molecular weight distribution, and more significant hypoglycemic effect.
- FIG. 1 is a molecular weight distribution diagram of Grifola frondosa polysaccharide (GFE) in Test Example 1.
- GFE Grifola frondosa polysaccharide
- FIG. 2 is a molecular weight distribution diagram of the Grifola frondosa active polysaccharide (GFH5) of the present invention in Test Example 1.
- FIG. 2 is a molecular weight distribution diagram of the Grifola frondosa active polysaccharide (GFH5) of the present invention in Test Example 1.
- the microfiltration permeate is introduced into the ultrafiltration equipment.
- the pore size of the ultrafiltration membrane corresponds to the molecular weight of 5KDa or more, the operating pressure is 0.5MPa, and the temperature is controlled at 35°C.
- the ultrafiltration is stopped. , retaining the ultrafiltration retentate that did not permeate the membrane to obtain 170L of the retentate;
- Grifola frondosa polysaccharide in Example 1 was prepared as a control.
- Grifola frondosa polysaccharide refers to the method of Test Example 1.
- Healthy male SD rats weighing 160-180 g, with 111 rats, were purchased from the Guangdong Provincial Medical Laboratory Animal Center. The rats were housed in the SPF animal room of the Guangdong Provincial Laboratory Animal Monitoring Institute at a temperature of 22-23°C and a relative humidity of 50-60%.
- Modeling method Feeding animals with high-sugar and high-fat diet can form an animal model of glucose metabolism disorder, and then intraperitoneal injection of alloxan can form insulin resistance, induce experimental diabetes, and form a type 2 diabetes rat model.
- Dosing method The recommended dose of human body (1.8g/d) was set as 112.5, 225, 675 mg/kg ⁇ BW for low, medium and high dose groups, which is equivalent to 5 times, 10 times and 30 times of the recommended dose of human body.
- the GFE group was given 675 mg/kg ⁇ BW by intragastric administration, which was equivalent to 30 times the recommended human dose.
- a normal control group and a negative control group were set up, and the same amount of vehicle was administered orally, and the positive control group was administered with metformin hydrochloride tablets 200 mg/kg by intragastric administration.
- the body weight was weighed every 3 days, and the amount of gavage was adjusted accordingly.
- the test samples were continuously gavaged for 48 days.
- Test method After the adaptation period, the rats were randomly divided into groups according to their body weight, with 15 rats in each of the normal group, model group and positive group, and 16 rats in each of the three dose groups of GFE and GFH5. The test samples of different concentrations were given to the stomach, the model control group was given the same volume of solvent, and the normal group was left untreated. After 3 consecutive weeks, the model control group and the sample group were fasted for 24 hours (without water), and given alloxan 103 mg/kg.BW intraperitoneal injection, the injection volume was 1 mL/100 g body weight. Continue to give high-calorie feed for 20 days after injection. On the 20th day after injection, the rats in each group were fasted for 4 hours, and fasting blood glucose and glucose tolerance were detected.
- the GFH5 low-dose and middle-dose administration groups had fasting blood glucose, blood glucose at 0.5, 2 hours after glucose administration, and 0, 0.5, and 2 hours.
- the reduction of the area under the blood glucose curve was statistically significant, so the results of fasting blood glucose and glucose tolerance indexes in the low-dose and middle-dose groups of GFH5 were determined to be positive.
- the model group there was no significant difference in the decrease of fasting blood glucose at high dose of GFH5, but the decrease of blood glucose and the area under the curve of blood glucose at 0.5 and 2 hours after glucose administration was statistically significant.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Sustainable Development (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a method for extracting grifola frondosa active polysaccharide on the basis of a membrane filtration technology, and grifola frondosa active polysaccharide extracted by the method and a use thereof. The method comprises: (1) adding water to a grifola frondosa sporocarp raw material, and performing combination and vacuum concentration to obtain a grifola frondosa extract concentrate; (2) performing microfiltration pretreatment on the grifola frondosa extract concentrate; (3) performing ultrafiltration treatment on the microfiltration permeate; and (4) drying the ultrafiltration retentate to obtain grifola frondosa polysaccharide. The present invention has beneficial effects that: (1) active components in the grifola frondosa extract are prevented from being damaged to the maximum extent, and a separation process is equivalent to primary pre-concentration; the ultrafiltration technology in the present invention is very suitable for separating effective components in the extract and removing components which are poor and even invalid in efficacy; the purity of the prepared grifola frondosa polysaccharide is higher than that of polysaccharide prepared by means of a conventional process; the ultrafiltration effect is improved, the membrane pollution is reduced, the production efficiency is improved, the service life of the ultrafiltration membrane is prolonged, and the costs are reduced; and the present invention is suitable for industrialization and has good economic prospects.
Description
本发明涉及一种多糖的提取方法,具体涉及一种基于膜过滤技术提取灰树花活性多糖的方法及该方法提取得到的灰树花活性多糖和用途。The invention relates to a method for extracting polysaccharide, in particular to a method for extracting active polysaccharide from Grifola frondosa based on membrane filtration technology, and the active polysaccharide from Grifola frondosa extracted by the method and its application.
灰树花是我国传统食药用菌,具有良好的保健作用和较高的药用价值。国内外的研究结果显示,灰树花具有减少胰岛素抵抗,控制血糖,抑制脂肪细胞堆积,降低血压,增强免疫和抗癌功效。Grifola frondosa is a traditional edible and medicinal fungus in my country, which has good health care function and high medicinal value. Research results at home and abroad show that Grifola has the effects of reducing insulin resistance, controlling blood sugar, inhibiting the accumulation of fat cells, lowering blood pressure, enhancing immunity and anti-cancer.
灰树花多糖是灰树花中的一种提取物,由葡聚糖和小分子单糖及少量蛋白质的异聚糖复合物组成,动物实验和临床实验显示,其可以通过活化吞噬细胞、诱导癌细胞凋亡等发挥防癌抗癌功效。Grifola frondosa polysaccharide is an extract from Grifola frondosa. It is composed of glucan, small molecule monosaccharide and a small amount of protein heterosaccharide complexes. Animal experiments and clinical experiments have shown that it can activate phagocytes, induce Apoptosis of cancer cells to play anti-cancer and anti-cancer effects.
目前,提取制备灰树花多糖一般采用水提取醇沉法,热水提取后加入乙醇除去水溶性蛋白、单糖等水溶性小分子杂质,沉淀得到粗多糖。然而,因为醇沉的纯化效率低,造成沉淀物中成分复杂,多糖含量降低,影响功效活性,且乙醇使用量大,导致多糖制备生产成本较高,且造成一定程度的环境污染。At present, the extraction and preparation of Grifola frondosa polysaccharides generally adopts water extraction and alcohol precipitation. After hot water extraction, ethanol is added to remove water-soluble small molecular impurities such as water-soluble proteins and monosaccharides, and crude polysaccharides are precipitated. However, because the purification efficiency of alcohol precipitation is low, the composition in the precipitate is complex, the polysaccharide content is reduced, the efficacy and activity is affected, and the amount of ethanol used is large, resulting in high polysaccharide preparation and production cost, and causing a certain degree of environmental pollution.
发明内容SUMMARY OF THE INVENTION
针对以上不足,本发明提供一种基于膜过滤技术提取灰树花活性多糖的方法,可以极大简化灰树花多糖的制备过程,提取的多糖纯度高,并且根据活性多糖的效果反向进行提取方法参数例如超滤参数等的筛选,使提取到的活性多糖效果显著,还实现提取方法的产业化应用。In view of the above deficiencies, the present invention provides a method for extracting Grifola frondosa active polysaccharide based on membrane filtration technology, which can greatly simplify the preparation process of Grifola frondosa polysaccharide, the extracted polysaccharide has high purity, and the extraction is performed in reverse according to the effect of the active polysaccharide. Screening of method parameters, such as ultrafiltration parameters, can make the extracted active polysaccharide have a significant effect, and also realize the industrial application of the extraction method.
本发明通过以下方案达到上述目的:The present invention achieves the above object through the following schemes:
第一方面,一种灰树花活性多糖的提取方法,包括:A first aspect, a method for extracting active polysaccharide from Grifola frondosa, comprising:
(1)向灰树花子实体原料中加入原料重量10-40倍的水,采用80-105℃提取1-4次,每次提取1-4小时,80-200目过滤提取液;合并提取液,真空浓缩至固形物含量5-20%得到灰树花提取浓缩液;(1) Add water 10-40 times the weight of the raw material to the Grifola frondosa fruiting body raw material, extract 1-4 times at 80-105 ° C, extract 1-4 hours each time, filter the extract at 80-200 mesh; merge the extract , vacuum concentrated to solid content 5-20% to obtain Grifola frondosa extract concentrate;
(2)将灰树花提取浓缩液进行微滤预处理,微滤膜孔径100-400nm,温度控制25-60℃,操作压力在1MPa以内,收集微滤透过液,弃去微滤未透过液;(2) Microfiltration pretreatment is carried out on the extract of Grifola frondosa, the pore size of the microfiltration membrane is 100-400nm, the temperature is controlled at 25-60°C, and the operating pressure is within 1MPa, the microfiltration permeate is collected, and the microfiltration unpermeable liquid is discarded. liquid;
(3)将微滤透过液进行超滤处理,超滤膜孔径对应截留1-18KDa分子量,操作压力0.3-1MPa,温度控制25-40℃,当透过液的体积在总体积的40%-75%时停止超滤,保留未透 过膜的超滤截留液,丢弃超滤透过液;(3) The microfiltration permeate is subjected to ultrafiltration treatment. The pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 1-18KDa, the operating pressure is 0.3-1MPa, and the temperature is controlled at 25-40°C. When the volume of the permeate is 40% of the total volume Stop the ultrafiltration when -75%, keep the ultrafiltration retentate that does not permeate the membrane, and discard the ultrafiltration permeate;
(4)将超滤截留液进行干燥,控制粉体水分含量<15%,所得干粉即为灰树花多糖。(4) drying the ultrafiltration retentate, and controlling the moisture content of the powder to be less than 15%, the obtained dry powder is the Grifola frondosa polysaccharide.
优选的,发明对上述提取方法参数进一步优化,得到一种提取效率更高,纯度更好的方法:一种灰树花活性多糖的提取方法,包括:Preferably, the invention further optimizes the parameters of the above extraction method to obtain a method with higher extraction efficiency and better purity: a method for extracting active polysaccharide from Grifola frondosa, comprising:
(1)向灰树花子实体原料中加入原料重量10-25倍的水,采用95-105℃提取2-3次,每次提取1-2小时,100-200目过滤提取液;合并提取液,真空浓缩至固形物含量10-18%得到灰树花提取浓缩液;(1) Add water 10-25 times the weight of the raw material to the Grifola frondosa fruiting body raw material, extract 2-3 times at 95-105°C, extract 1-2 hours each time, filter the extract with 100-200 mesh; merge the extract , vacuum concentrated to solid content 10-18% to obtain Grifola frondosa extract concentrate;
(2)将灰树花提取浓缩液进行微滤预处理,微滤膜孔径100-200nm,温度控制25-55℃,操作压力在0.8MPa以内,收集微滤透过液,弃去微滤未透过液;(2) Microfiltration pretreatment is carried out on the extract of Grifola frondosa, the pore size of the microfiltration membrane is 100-200 nm, the temperature is controlled at 25-55 °C, and the operating pressure is within 0.8 MPa, the microfiltration permeate is collected, and the microfiltration unfiltered liquid is discarded. permeate;
(3)将微滤透过液进行超滤处理,超滤膜孔径对应截留2-15KDa分子量,操作压力0.3-0.6MPa,温度控制25-35℃,当透过液的体积在总体积的55%-75%时停止超滤,保留未透过膜的超滤截留液,丢弃超滤透过液;(3) The microfiltration permeate is subjected to ultrafiltration treatment, the pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 2-15KDa, the operating pressure is 0.3-0.6MPa, and the temperature is controlled at 25-35°C. When the volume of the permeate is 55% of the total volume %-75%, stop the ultrafiltration, keep the ultrafiltration retentate that does not pass through the membrane, and discard the ultrafiltration permeate;
(4)将超滤截留液进行干燥,控制粉体水分含量<12%,所得干粉即为灰树花多糖。(4) drying the ultrafiltration retentate, and controlling the moisture content of the powder to be less than 12%, the obtained dry powder is the Grifola frondosa polysaccharide.
发明人发现,在灰树花提取液中,灰树花水溶性氨基酸和单糖等成分的相对分子质量一般都低于1KDa,而淀粉、纤维素等相对分子量很大,因此采用超滤技术非常适合分离提取液中的有效成分而去除与功效性较差、甚至无效的成分。The inventor found that in the Grifola frondosa extract, the relative molecular weights of the components such as Grifola frondosa water-soluble amino acids and monosaccharides are generally lower than 1KDa, while the relative molecular weights such as starch and cellulose are very large, so the use of ultrafiltration technology is very important. It is suitable for separating the effective components in the extract and removing the components with poor efficacy or even ineffectiveness.
在本发明提供的制备方法中,分离过程相当于一次预浓缩,然后采用微滤和超滤技术联用,具有操作简单,能耗低,生产周期短,滤膜可多次使用,过滤全程低温操作且不存在溶剂残留,最大限度防止破坏灰树花提取液中活性成分,结果表明:所制备的灰树花多糖纯度远高于传统工艺制备的灰树花多糖。In the preparation method provided by the present invention, the separation process is equivalent to one-time pre-concentration, and then the microfiltration and ultrafiltration technologies are used in combination, which has the advantages of simple operation, low energy consumption, short production cycle, the filter membrane can be used multiple times, and the whole process of filtration is low temperature. There is no solvent residue in the operation, which can prevent the destruction of the active components in the Grifola frondosa extract to the greatest extent.
进一步地,发明人将实验室规模的提取方法不断方法,调整,得到可以工业化的一种灰树花活性多糖的提取方法,包括:Further, the inventor continuously adjusted the laboratory-scale extraction method to obtain an industrialized extraction method for Grifola frondosa active polysaccharide, including:
(1)将灰树花子实体原料投入提取罐中,加入原料重量10-40倍的水,采用80-105℃提取1-4次,每次提取1-4小时,将提取液通过过滤网,过滤网的孔径为80-200目;合并提取液,真空浓缩至固形物含量5-20%得到灰树花提取浓缩液;(1) Put the Grifola frondosa fruit body raw material into the extraction tank, add water 10-40 times the weight of the raw material, extract 1-4 times at 80-105 ° C, extract 1-4 hours each time, pass the extract through the filter, The aperture of the filter screen is 80-200 meshes; the extracts are combined and concentrated in vacuo to a solid content of 5-20% to obtain the Grifola frondosa extraction concentrate;
(2)将灰树花提取浓缩液引入微滤设备进行预处理,微滤膜孔径100-400nm,温度控制25-60℃,操作压力在1MPa以内,收集微滤透过液,弃去微滤未透过液;(2) Introduce the extract concentrate of Grifola frondosa into the microfiltration equipment for pretreatment, the pore size of the microfiltration membrane is 100-400nm, the temperature is controlled at 25-60°C, and the operating pressure is within 1MPa, the microfiltration permeate is collected, and the microfiltration is discarded. no permeate;
(3)将微滤透过液引入超滤设备,用超滤膜对不同分子量的多糖进行截留纯化,超滤膜孔径对应截留1-18KDa的分子量,操作压力0.3-1MPa,温度控制25-40℃,控制透过液的体积在总体积的40%-75%时,停止超滤,保留未透过膜的超滤截留液,弃超滤透过液;(3) The microfiltration permeate is introduced into the ultrafiltration equipment, and the polysaccharides of different molecular weights are intercepted and purified with an ultrafiltration membrane. The pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 1-18KDa, the operating pressure is 0.3-1MPa, and the temperature is controlled at 25-40 ℃, when the volume of the permeate is controlled at 40%-75% of the total volume, the ultrafiltration is stopped, the ultrafiltration retentate that does not permeate the membrane is retained, and the ultrafiltration permeate is discarded;
(4)将超滤截留液进行干燥,控制成品粉体水分含量<15%,所得干粉即为灰树花多糖成品。(4) drying the ultrafiltration retentate, and controlling the moisture content of the finished powder to be less than 15%, the obtained dry powder is the finished product of Grifola frondosa polysaccharide.
进一步地,发明人结合上述对提取效率和纯度所做的研究,在实验室规模的提取方法中成功优化可以工业化的灰树花活性多糖的提取方法,包括:Further, the inventor has successfully optimized the extraction method of the industrialized Grifola frondosa active polysaccharide in the laboratory-scale extraction method in combination with the above-mentioned research on extraction efficiency and purity, including:
(1)将灰树花子实体原料投入提取罐中,加入原料重量10-25倍的水,采用95-105℃提取2-3次,每次提取1-2小时,将提取液通过过滤网,过滤网的孔径为100-200目;合并提取液,真空浓缩至固形物含量10-18%得到灰树花提取浓缩液;(1) put the Grifola frondosa fruit body raw material into the extraction tank, add 10-25 times of water of the raw material weight, extract 2-3 times at 95-105 ° C, extract 1-2 hours each time, and pass the extract through the filter screen, The aperture of the filter screen is 100-200 meshes; the extracts are combined and concentrated to a solid content of 10-18% in a vacuum to obtain a Grifola frondosa extraction concentrate;
(2)将灰树花提取浓缩液引入微滤设备进行预处理,微滤膜孔径100-200nm,温度控制25-55℃,操作压力在0.8MPa以内,收集微滤透过液,弃去微滤未透过液;(2) Introduce the concentrated liquid of Grifola frondosa extraction into the microfiltration equipment for pretreatment, the microfiltration membrane pore size is 100-200nm, the temperature is controlled at 25-55°C, and the operating pressure is within 0.8MPa, the microfiltration permeate is collected, and the microfiltration permeate is discarded. Filter the permeate;
(3)将微滤透过液引入超滤设备,用超滤膜对不同分子量的多糖进行截留纯化,超滤膜孔径对应截留2-15KDa分子量,操作压力0.3-0.6MPa,温度控制25-35℃,控制透过液的体积在总体积的55%-75%时,停止超滤,保留未透过膜的超滤截留液,弃超滤透过液;(3) The microfiltration permeate is introduced into the ultrafiltration equipment, and the polysaccharides of different molecular weights are intercepted and purified by the ultrafiltration membrane. The pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 2-15KDa, the operating pressure is 0.3-0.6MPa, and the temperature is controlled at 25-35 ℃, when the volume of the permeate is controlled at 55%-75% of the total volume, the ultrafiltration is stopped, the ultrafiltration retentate that does not permeate the membrane is retained, and the ultrafiltration permeate is discarded;
(4)将超滤截留液进行干燥,控制成品粉体水分含量<12%,所得干粉即为灰树花多糖成品。(4) drying the ultrafiltration retentate, and controlling the moisture content of the finished powder to be less than 12%, the obtained dry powder is the finished product of Grifola frondosa polysaccharide.
优选的,所述的超滤截留液的干燥包括:喷雾干燥、冷冻干燥、真空干燥或常压干燥方法中的一种或几种。Preferably, the drying of the ultrafiltration retentate includes: one or more of spray drying, freeze drying, vacuum drying or normal pressure drying.
优选的,所述的微滤膜材料为陶瓷膜、有机高分子膜、金属膜中的一种或几种。Preferably, the microfiltration membrane material is one or more of ceramic membranes, organic polymer membranes, and metal membranes.
优选的,所述的超滤膜孔径小于100nm,截留分子量范围1-18KDa,超滤膜材料为陶瓷膜、有机高分子膜、金属膜中的一种或几种。Preferably, the pore size of the ultrafiltration membrane is less than 100 nm, the molecular weight cutoff is in the range of 1-18KDa, and the ultrafiltration membrane material is one or more of ceramic membranes, organic polymer membranes, and metal membranes.
在上述灰树花活性多糖的提取方法中,所述的微滤操作属于一种物理的提取液预处理方法,类似的还可以采用减压抽滤、活性炭脱色、低速离心、高速离心等预处理方法;但是,发明人发现,采用微滤和超滤联用更利于灰树花活性多糖的提取以及超滤膜寿命,节省提取成本。In the above-mentioned extraction method of Grifola frondosa active polysaccharide, the microfiltration operation belongs to a physical extraction liquid pretreatment method, and similar pretreatments such as vacuum filtration, activated carbon decolorization, low-speed centrifugation, and high-speed centrifugation can also be used. method; however, the inventor found that the combination of microfiltration and ultrafiltration is more conducive to the extraction of Grifola frondosa active polysaccharide and the life of the ultrafiltration membrane, and the extraction cost is saved.
第二方法,本发明提供一种上述提取方法提取得到的灰树花多糖。The second method, the present invention provides a Grifola frondosa polysaccharide extracted by the above extraction method.
该灰树花多糖的成分分析如图2和表2所示。The composition analysis of the Grifola frondosa polysaccharide is shown in Figure 2 and Table 2.
与传统方法制备的灰树花多糖相比,灰树花活性多糖分子量分布更为集中,纯度更高。Compared with the Grifola frondosa polysaccharide prepared by the traditional method, the molecular weight distribution of the Grifola frondosa active polysaccharide is more concentrated and the purity is higher.
第三方面,本发明提供上述提取得到的灰树花活性多糖在降血糖方面的用途。In a third aspect, the present invention provides the use of the Grifola frondosa active polysaccharide obtained by the above extraction in hypoglycemic.
第四方面,本发明提供上述提取得到的灰树花活性多糖在制备降血糖药物方面的用途。In a fourth aspect, the present invention provides the use of the Grifola frondosa active polysaccharide obtained by the above extraction in preparing a hypoglycemic drug.
与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
(1)采用微滤和超滤技术具有操作简单,能耗低,生产周期短,滤膜可多次使用,过滤 全程属于低温操作且不存在溶剂残留,最大限度防止破坏灰树花提取液中活性成分,同时分离过程相当于一次预浓缩;(1) The use of microfiltration and ultrafiltration technology has the advantages of simple operation, low energy consumption, short production cycle, and the filter membrane can be used multiple times. Active ingredients, while the separation process is equivalent to a pre-concentration;
(2)灰树花水溶性氨基酸和单糖等成分的相对分子质量一般都低于1KDa,而淀粉、纤维素等相对分子量很大,因此本发明的超滤技术非常适合分离提取液中的有效成分,而去除与功效性较差、甚至无效的成分,所制备的灰树花多糖纯度高于传统工艺制备多糖;(2) The relative molecular weights of components such as Grifola frondosa water-soluble amino acids and monosaccharides are generally lower than 1KDa, while relative molecular weights such as starch and cellulose are very large, so the ultrafiltration technology of the present invention is very suitable for separating the effective The purity of the prepared Grifola polysaccharide is higher than that of the polysaccharide prepared by the traditional process;
(3)本发明中超滤前采用微滤处理提取液除去提取液中较大的悬浮颗粒或胶状物质,提高超滤效果,减轻膜污染,有利于提高生产效率,延长超滤膜使用寿命,节省成本;(3) In the present invention, the extraction solution is treated by microfiltration before ultrafiltration to remove larger suspended particles or colloidal substances in the extraction solution, thereby improving the ultrafiltration effect, reducing membrane pollution, helping to improve production efficiency and prolonging the service life of ultrafiltration membranes ,cut costs;
(4)操作过程不涉及乙醇,节约了生产成本,同时提高了生产操作便捷性和安全性。(4) The operation process does not involve ethanol, which saves the production cost and improves the convenience and safety of the production operation at the same time.
(5)本发明的方法适用于工业化,经济前景好。(5) The method of the present invention is suitable for industrialization and has good economic prospects.
(6)本发明提取的灰树花多糖的纯度更高,分子量分布更集中,其降血糖效果更显著。(6) The Grifola frondosa polysaccharide extracted by the present invention has higher purity, more concentrated molecular weight distribution, and more significant hypoglycemic effect.
图1为试验例1中的普通灰树花多糖(GFE)的分子量分布图。FIG. 1 is a molecular weight distribution diagram of Grifola frondosa polysaccharide (GFE) in Test Example 1. FIG.
图2为试验例1中的本发明的灰树花活性多糖(GFH5)的分子量分布图。FIG. 2 is a molecular weight distribution diagram of the Grifola frondosa active polysaccharide (GFH5) of the present invention in Test Example 1. FIG.
以下结合具体实施例对本发明进行进一步说明。The present invention will be further described below in conjunction with specific embodiments.
实施例1:Example 1:
(1)将100kg水分含量约为12%的灰树花子实体投入提取罐,加入25倍水,100℃提取4h,提取液过100目滤网,引入双效浓缩装置,浓缩至固形物含量10%的浓缩液,得到470L浓缩液;(1) Put 100kg of Grifola frondosa fruit bodies with a moisture content of about 12% into the extraction tank, add 25 times of water, extract at 100 ° C for 4 hours, pass the extract through a 100-mesh filter screen, introduce a double-effect concentration device, and concentrate to a solid content of 10 % concentrated solution to obtain 470L of concentrated solution;
(2)将浓缩液引入微滤设备,滤膜孔径200nm,温度55℃,操作压力低于0.5MPa,透过液收率90%;(2) The concentrated solution is introduced into the microfiltration equipment, the pore size of the filter membrane is 200 nm, the temperature is 55 ° C, the operating pressure is lower than 0.5 MPa, and the permeate yield is 90%;
(3)将微滤透过液引入超滤设备,超滤膜孔径对应截留5KDa以上的分子量,操作压力0.5MPa,温度控制在35℃,当透过液达到总体积的60%时停止超滤,保留未透过膜的超滤截留液,得到截留液170L;(3) The microfiltration permeate is introduced into the ultrafiltration equipment. The pore size of the ultrafiltration membrane corresponds to the molecular weight of 5KDa or more, the operating pressure is 0.5MPa, and the temperature is controlled at 35°C. When the permeate reaches 60% of the total volume, the ultrafiltration is stopped. , retaining the ultrafiltration retentate that did not permeate the membrane to obtain 170L of the retentate;
(4)将超滤截留液引入喷雾干燥装置,控制进风温度170℃,喷雾干燥至粉体水分含量约10%,所得干粉即为灰树花多糖成品。(4) Introducing the ultrafiltration retentate into a spray drying device, controlling the inlet air temperature to 170° C., spray drying to a powder moisture content of about 10%, and the obtained dry powder is the Grifola frondosa polysaccharide finished product.
最终得到成品9.57kg,成品中多糖含量为4.38g/100g。Finally, 9.57kg of finished product was obtained, and the polysaccharide content in the finished product was 4.38g/100g.
试验例1Test Example 1
采用实施例1中的灰树花多糖样品(命名为GFH5),同时制备普通灰树花多糖(命名为GFE),测定两种样品的多糖分子量分布。Using the Grifola frondosa polysaccharide sample (named GFH5) in Example 1, and preparing common Grifola frondosa polysaccharide (named GFE) at the same time, the polysaccharide molecular weight distribution of the two samples was determined.
其中,普通灰树花多糖的制备方法:Wherein, the preparation method of common Grifola frondosa polysaccharide:
(1)将100kg水分含量约为12%的灰树花子实体投入提取罐,加入25倍水,100℃提取4h,提取液过100目滤网,引入双效浓缩装置,浓缩至固形物含量10%的浓缩液,得到470L浓缩液;(1) Put 100kg of Grifola frondosa fruit bodies with a moisture content of about 12% into the extraction tank, add 25 times of water, extract at 100 ° C for 4 hours, pass the extract through a 100-mesh filter screen, introduce a double-effect concentration device, and concentrate to a solid content of 10 % concentrated solution to obtain 470L of concentrated solution;
(2)将浓缩液引入喷雾干燥装置,控制进风温度170℃,喷雾干燥至粉体水分含量约10%,所得干粉即为普通灰树花多糖成品。(2) Introducing the concentrated solution into a spray drying device, controlling the inlet air temperature to 170° C., spray drying to a powder moisture content of about 10%, and the obtained dry powder is the finished product of Grifola frondosa polysaccharide.
测定结果如表1-表2和图1及图2所示:The measurement results are shown in Table 1-Table 2 and Figure 1 and Figure 2:
表1:普通灰树花多糖(GFE)Table 1: Grifola frondosa polysaccharide (GFE)
序号serial number | 保留时间keep time | 峰面积%Peak area% | 数均分子量number average molecular weight | 重均分子量weight average molecular weight |
11 | 44.96744.967 | 2.662.66 | 1345213452 | 1394513945 |
22 | 50.02550.025 | 16.6916.69 | 14151415 | 15011501 |
33 | 51.80051.800 | 80.6580.65 | 515515 | 536536 |
表2:灰树花活性多糖(GFH5)Table 2: Grifola frondosa active polysaccharide (GFH5)
序号serial number | 保留时间keep time | 峰面积%Peak area% | 数均分子量number average molecular weight | 重均分子量weight average molecular weight |
11 | 17.41717.417 | 7.217.21 | 1403214032 | 1689216892 |
22 | 19.21719.217 | 36.0036.00 | 19601960 | 27552755 |
33 | 20.05220.052 | 56.7956.79 | 302302 | 397397 |
从图1和图2及表1和表2的结果可以看出,与传统工艺制备的普通灰树花多糖相比,本发明提取的的灰树花活性多糖分子量分布更为集中,纯度高于传统工艺制备的多糖。As can be seen from the results of Figure 1 and Figure 2 and Table 1 and Table 2, compared with the common Grifola frondosa polysaccharide prepared by the traditional process, the molecular weight distribution of the Grifola frondosa active polysaccharide extracted by the present invention is more concentrated, and the purity is higher than Polysaccharides prepared by traditional techniques.
试验例2Test Example 2
采用实施例1中的灰树花多糖为样品(命名为GFH5)进行动物实验评价降血糖活性。同时制备普通灰树花多糖(GFE)作为对照。Using the Grifola frondosa polysaccharide in Example 1 as a sample (named GFH5), animal experiments were performed to evaluate the hypoglycemic activity. At the same time, Grifola frondosa polysaccharide (GFE) was prepared as a control.
普通灰树花多糖(GFE)的制备参照试验例1的方法。The preparation of Grifola frondosa polysaccharide (GFE) refers to the method of Test Example 1.
1、方法1. Method
健康雄性SD大鼠,体重160-180g,数量111只,购自广东省医学实验动物中心。大鼠饲养于广东省实验动物监测所SPF级动物房,温度22-23℃,相对湿度为50-60%。Healthy male SD rats, weighing 160-180 g, with 111 rats, were purchased from the Guangdong Provincial Medical Laboratory Animal Center. The rats were housed in the SPF animal room of the Guangdong Provincial Laboratory Animal Monitoring Institute at a temperature of 22-23°C and a relative humidity of 50-60%.
造模方法:用含有高糖高脂的饲料喂养动物可形成糖代谢紊乱动物模型,再给予剂量四氧嘧啶腹腔注射,可形成胰岛素抵抗,诱发实验性糖尿病,形成2型糖尿病大鼠模型。Modeling method: Feeding animals with high-sugar and high-fat diet can form an animal model of glucose metabolism disorder, and then intraperitoneal injection of alloxan can form insulin resistance, induce experimental diabetes, and form a type 2 diabetes rat model.
给药方法:以人体推荐量(1.8g/d)设低、中、高剂量组为112.5、225、675mg/kg·BW,相当于人体推荐量的5倍,10倍和30倍。GFE组以675mg/kg·BW灌胃,相当于人体推荐剂量的30倍。同时设置正常对照组和阴性对照组,灌胃等量溶媒,以及阳性对照组,灌胃盐酸二甲双胍片200mg/kg。每3d称量一次体重,据此调整灌胃量。受试样品连续灌胃48天。 试验方法:适应期结束后,将大鼠按体重随机分组,正常组、模型组、阳性组每组15只,GFE、GFH5三个剂量组每组16只,各组给予维持饲料,样品组灌胃给予不同浓度受试样品,模型对照组给予同体积溶剂,正常组不做处理,连续1周后,除正常组给予维持饲料外,其他组均给予高热能饲料并灌胃。连续3周后,模型对照组和样品组禁食24小时(不禁水),给予四氧嘧啶103mg/kg.BW腹腔注射,注射量1mL/100g体重。注射后继续给予高热能饲料喂饲20天。在注射后的第20天将各组大鼠禁食4小时,检测空腹血糖、糖耐量。Dosing method: The recommended dose of human body (1.8g/d) was set as 112.5, 225, 675 mg/kg·BW for low, medium and high dose groups, which is equivalent to 5 times, 10 times and 30 times of the recommended dose of human body. The GFE group was given 675 mg/kg·BW by intragastric administration, which was equivalent to 30 times the recommended human dose. At the same time, a normal control group and a negative control group were set up, and the same amount of vehicle was administered orally, and the positive control group was administered with metformin hydrochloride tablets 200 mg/kg by intragastric administration. The body weight was weighed every 3 days, and the amount of gavage was adjusted accordingly. The test samples were continuously gavaged for 48 days. Test method: After the adaptation period, the rats were randomly divided into groups according to their body weight, with 15 rats in each of the normal group, model group and positive group, and 16 rats in each of the three dose groups of GFE and GFH5. The test samples of different concentrations were given to the stomach, the model control group was given the same volume of solvent, and the normal group was left untreated. After 3 consecutive weeks, the model control group and the sample group were fasted for 24 hours (without water), and given alloxan 103 mg/kg.BW intraperitoneal injection, the injection volume was 1 mL/100 g body weight. Continue to give high-calorie feed for 20 days after injection. On the 20th day after injection, the rats in each group were fasted for 4 hours, and fasting blood glucose and glucose tolerance were detected.
动物分组如表3所示:Animal groupings are shown in Table 3:
表3实验动物分组及给药剂量Table 3 Experimental animal groupings and doses
组别(n=7)Group (n=7) | 动物数/只Number of animals/only | 给药剂量/mg/kgDosage/mg/kg |
正常对照组normal control group | 1515 | |
高糖模型对照组High glucose model control group | 1515 | 溶剂solvent |
阳性对照组(二甲双胍)Positive control group (metformin) | 1515 | 200200 |
GFH5-低剂量GFH5 - low dose | 1616 | 112.5112.5 |
GFH5-中剂量GFH5-medium dose | 1616 | 225225 |
GFH5-高剂量GFH5 - high dose | 1616 | 675675 |
GFEGFE | 1616 | 675675 |
2、结果2. Results
造模第20天大鼠空腹血糖及糖耐量结果如表4所示。The results of fasting blood glucose and glucose tolerance of rats on the 20th day of modeling are shown in Table 4.
表4不同样品对糖尿病大鼠血糖及糖耐量的影响Table 4 Effects of different samples on blood glucose and glucose tolerance in diabetic rats
注:与正常组组相比,*P<0.05;**P<0.01;与模型组相比,
#P<0.05;
##P≤0.01。
Note: Compared with the normal group, *P<0.05;**P<0.01; compared with the model group, # P<0.05;## P≤0.01.
由表4可知,在造模的第20天,GFH5低剂量和中剂量给药组与模型对照组比较,空腹血糖、在给葡萄糖后0.5、2小时各个时间点血糖及0、0.5、2小时血糖曲线下面积降低均具有统计学意义,故判定GFH5低剂量和中剂量给药组空腹血糖和糖耐量指标结果阳性。GFH5高剂量空腹血糖下降与模型组比较无显著性差异,而在给葡萄糖后0.5、2小时各个时间点血糖及0、0.5、2小时血糖曲线下面积降低具有统计学意义。As can be seen from Table 4, on the 20th day of modeling, compared with the model control group, the GFH5 low-dose and middle-dose administration groups had fasting blood glucose, blood glucose at 0.5, 2 hours after glucose administration, and 0, 0.5, and 2 hours. The reduction of the area under the blood glucose curve was statistically significant, so the results of fasting blood glucose and glucose tolerance indexes in the low-dose and middle-dose groups of GFH5 were determined to be positive. Compared with the model group, there was no significant difference in the decrease of fasting blood glucose at high dose of GFH5, but the decrease of blood glucose and the area under the curve of blood glucose at 0.5 and 2 hours after glucose administration was statistically significant.
结果表明:GFE给药组无降血糖效果,GFH5各剂量组降血糖作用显著,尤其是GFH5 低剂量组和中剂量组。说明本发明方法制备的灰树花多糖具有良好的降血糖活性。The results showed that the GFE administration group had no hypoglycemic effect, and the hypoglycemic effect of each dose group of GFH5 was significant, especially the low dose group and the middle dose group of GFH5. It shows that the Grifola frondosa polysaccharide prepared by the method of the present invention has good hypoglycemic activity.
以上所述,仅为本发明的较佳的具体实施例,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其构思加以等同替换或改变,都应涵盖在本发明的保护范围内。The above are only preferred specific embodiments of the present invention, but the protection scope of the present invention is not limited thereto. The equivalent replacement or modification of the solution and its concept shall be included within the protection scope of the present invention.
Claims (9)
- 一种灰树花活性多糖的提取方法,其特征在于,包括:A method for extracting Grifola frondosa active polysaccharide, comprising:(1)向灰树花子实体原料中加入原料重量10-40倍的水,采用80-105℃提取1-4次,每次提取1-4小时,80-200目过滤提取液;合并提取液,真空浓缩至固形物含量5-20%得到灰树花提取浓缩液;(1) Add water of 10-40 times the weight of the raw material to the Grifola frondosa fruiting body raw material, extract 1-4 times at 80-105 ° C, extract 1-4 hours each time, filter the extract at 80-200 mesh; merge the extract , vacuum concentrated to solid content 5-20% to obtain Grifola frondosa extract concentrate;(2)将灰树花提取浓缩液进行微滤预处理,微滤膜孔径100-400nm,温度控制25-60℃,操作压力在1MPa以内,收集微滤透过液,弃去微滤未透过液;(2) Microfiltration pretreatment is carried out on the extract of Grifola frondosa, the pore size of the microfiltration membrane is 100-400nm, the temperature is controlled at 25-60°C, and the operating pressure is within 1MPa, the microfiltration permeate is collected, and the microfiltration unpermeable liquid is discarded. liquid;(3)将微滤透过液进行超滤处理,超滤膜孔径对应截留1-18KDa分子量,操作压力0.3-1MPa,温度控制25-40℃,当透过液的体积在总体积的40%-75%时停止超滤,保留未透过膜的超滤截留液,丢弃超滤透过液;(3) The microfiltration permeate is subjected to ultrafiltration treatment. The pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 1-18KDa, the operating pressure is 0.3-1MPa, and the temperature is controlled at 25-40°C. When the volume of the permeate is 40% of the total volume Stop the ultrafiltration when -75%, keep the ultrafiltration retentate that does not permeate the membrane, and discard the ultrafiltration permeate;(4)将超滤截留液进行干燥,控制粉体水分含量<15%,所得干粉即为灰树花多糖。(4) drying the ultrafiltration retentate, and controlling the moisture content of the powder to be less than 15%, the obtained dry powder is the Grifola frondosa polysaccharide.
- 根据权利要求1所述的一种灰树花活性多糖的提取方法,其特征在于,包括:The extraction method of a kind of Grifola frondosa active polysaccharide according to claim 1, is characterized in that, comprises:(1)向灰树花子实体原料中加入原料重量10-25倍的水,采用95-105℃提取2-3次,每次提取1-2小时,100-200目过滤提取液;合并提取液,真空浓缩至固形物含量10-18%得到灰树花提取浓缩液;(1) add water 10-25 times the weight of the raw material to the Grifola frondosa fruiting body raw material, extract 2-3 times at 95-105 ° C, extract 1-2 hours each time, filter the extract at 100-200 mesh; merge the extract , vacuum concentrated to solid content 10-18% to obtain Grifola frondosa extract concentrate;(2)将灰树花提取浓缩液进行微滤预处理,微滤膜孔径100-200nm,温度控制25-55℃,操作压力在0.8MPa以内,收集微滤透过液,弃去微滤未透过液;(2) Perform microfiltration pretreatment on the extract of Grifola frondosa, the pore size of the microfiltration membrane is 100-200 nm, the temperature is controlled at 25-55 °C, and the operating pressure is within 0.8 MPa, the microfiltration permeate is collected, and the microfiltration untreated permeate;(3)将微滤透过液进行超滤处理,超滤膜孔径对应截留2-15KDa分子量,操作压力0.3-0.6MPa,温度控制25-35℃,当透过液的体积在总体积的55%-75%时停止超滤,保留未透过膜的超滤截留液,丢弃超滤透过液;(3) The microfiltration permeate is subjected to ultrafiltration treatment, the pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 2-15KDa, the operating pressure is 0.3-0.6MPa, and the temperature is controlled at 25-35°C. When the volume of the permeate is 55% of the total volume %-75%, stop the ultrafiltration, keep the ultrafiltration retentate that does not pass through the membrane, and discard the ultrafiltration permeate;(4)将超滤截留液进行干燥,控制粉体水分含量<12%,所得干粉即为灰树花多糖。(4) drying the ultrafiltration retentate, and controlling the moisture content of the powder to be less than 12%, the obtained dry powder is the Grifola frondosa polysaccharide.
- 工业化的一种灰树花活性多糖的提取方法,其特征在于,包括:An industrialized method for extracting active polysaccharide from Grifola frondosa, characterized in that it comprises:(1)将灰树花子实体原料投入提取罐中,加入原料重量10-40倍的水,采用80-105℃提取1-4次,每次提取1-4小时,将提取液通过过滤网,过滤网的孔径为80-200目;合并提取液,真空浓缩至固形物含量5-20%得到灰树花提取浓缩液;(1) Put the Grifola frondosa fruit body raw material into the extraction tank, add water 10-40 times the weight of the raw material, extract 1-4 times at 80-105 ° C, extract 1-4 hours each time, pass the extract through the filter, The aperture of the filter screen is 80-200 meshes; the extracts are combined and concentrated in vacuo to a solid content of 5-20% to obtain the Grifola frondosa extraction concentrate;(2)将灰树花提取浓缩液引入微滤设备进行预处理,微滤膜孔径100-400nm,温度控制25-60℃,操作压力在1MPa以内,收集微滤透过液,弃去微滤未透过液;(2) Introduce the extract concentrate of Grifola frondosa into the microfiltration equipment for pretreatment, the pore size of the microfiltration membrane is 100-400nm, the temperature is controlled at 25-60°C, and the operating pressure is within 1MPa, the microfiltration permeate is collected, and the microfiltration is discarded. no permeate;(3)将微滤透过液引入超滤设备,用超滤膜对不同分子量的多糖进行截留纯化,超滤膜孔径对应截留1-18KDa的分子量,操作压力0.3-1MPa,温度控制25-40℃,控制透过液的体积在总体积的40%-75%时,停止超滤,保留未透过膜的超滤截留液,弃超滤透过液;(3) The microfiltration permeate is introduced into the ultrafiltration equipment, and the polysaccharides of different molecular weights are intercepted and purified with an ultrafiltration membrane. The pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 1-18KDa, the operating pressure is 0.3-1MPa, and the temperature is controlled at 25-40 ℃, when the volume of the permeate is controlled at 40%-75% of the total volume, the ultrafiltration is stopped, the ultrafiltration retentate that does not permeate the membrane is retained, and the ultrafiltration permeate is discarded;(4)将超滤截留液进行干燥,控制成品粉体水分含量<15%,所得干粉即为灰树花多糖 成品。(4) the ultrafiltration retentate is dried, and the moisture content of the finished powder is controlled to be less than 15%, and the obtained dry powder is the Grifola frondosa polysaccharide finished product.
- 根据权利要求3所述的工业化的灰树花活性多糖的提取方法,其特征在于,包括:The extraction method of industrialized Grifola frondosa active polysaccharide according to claim 3, is characterized in that, comprises:(1)将灰树花子实体原料投入提取罐中,加入原料重量10-25倍的水,采用95-105℃提取2-3次,每次提取1-2小时,将提取液通过过滤网,过滤网的孔径为100-200目;合并提取液,真空浓缩至固形物含量10-18%得到灰树花提取浓缩液;(1) put the Grifola frondosa fruit body raw material into the extraction tank, add 10-25 times of water of the raw material weight, extract 2-3 times at 95-105 ° C, extract 1-2 hours each time, and pass the extract through the filter screen, The pore size of the filter screen is 100-200 mesh; the extracts are combined and concentrated in vacuo to a solid content of 10-18% to obtain the Grifola frondosa extraction concentrate;(2)将灰树花提取浓缩液引入微滤设备进行预处理,微滤膜孔径100-200nm,温度控制25-55℃,操作压力在0.8MPa以内,收集微滤透过液,弃去微滤未透过液;(2) Introduce the concentrated liquid of Grifola frondosa extraction into the microfiltration equipment for pretreatment, the microfiltration membrane pore size is 100-200nm, the temperature is controlled at 25-55°C, and the operating pressure is within 0.8MPa, the microfiltration permeate is collected, and the microfiltration permeate is discarded. Filter the permeate;(3)将微滤透过液引入超滤设备,用超滤膜对不同分子量的多糖进行截留纯化,超滤膜孔径对应截留2-15KDa分子量,操作压力0.3-0.6MPa,温度控制25-35℃,控制透过液的体积在总体积的55%-75%时,停止超滤,保留未透过膜的超滤截留液,弃超滤透过液;(3) The microfiltration permeate is introduced into the ultrafiltration equipment, and the polysaccharides of different molecular weights are intercepted and purified by the ultrafiltration membrane. The pore size of the ultrafiltration membrane corresponds to the intercepted molecular weight of 2-15KDa, the operating pressure is 0.3-0.6MPa, and the temperature is controlled at 25-35 ℃, when the volume of the permeate is controlled at 55%-75% of the total volume, the ultrafiltration is stopped, the ultrafiltration retentate that does not permeate the membrane is retained, and the ultrafiltration permeate is discarded;(4)将超滤截留液进行干燥,控制成品粉体水分含量<12%,所得干粉即为灰树花多糖成品。(4) drying the ultrafiltration retentate, and controlling the moisture content of the finished powder to be less than 12%, the obtained dry powder is the finished product of Grifola frondosa polysaccharide.
- 根据权利要求1-4中任一所述的提取方法,其特征在于,所述的超滤截留液的干燥包括:喷雾干燥、冷冻干燥、真空干燥或常压干燥方法中的一种或几种。The extraction method according to any one of claims 1-4, wherein the drying of the ultrafiltration retentate comprises: one or more of spray drying, freeze drying, vacuum drying or atmospheric drying methods .
- 根据权利要求1-4中任一所述的提取方法,其特征在于,所述的微滤膜材料为陶瓷膜、有机高分子膜、金属膜中的一种或几种。The extraction method according to any one of claims 1-4, wherein the microfiltration membrane material is one or more of a ceramic membrane, an organic polymer membrane, and a metal membrane.
- 根据权利要求1-4中任一所述的提取方法,其特征在于,所述的超滤膜孔径小于100nm,截留分子量范围1-18KDa,超滤膜材料为陶瓷膜、有机高分子膜、金属膜中的一种或几种。The extraction method according to any one of claims 1-4, wherein the pore size of the ultrafiltration membrane is less than 100 nm, the molecular weight cut-off range is 1-18KDa, and the ultrafiltration membrane material is ceramic membrane, organic polymer membrane, metal one or more of the membranes.
- 一种权利要求1-7中任一所述的提取方法提取得到的灰树花多糖。A Grifola frondosa polysaccharide obtained by the extraction method according to any one of claims 1-7.
- 权利要求8所述的灰树花活性多糖在制备降血糖药物方面的用途。The use of the Grifola frondosa active polysaccharide according to claim 8 in the preparation of a hypoglycemic medicament.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011101483.6 | 2020-10-15 | ||
CN202011101483.6A CN112225827A (en) | 2020-10-15 | 2020-10-15 | Extraction method of active polysaccharide of grifola frondosa, extracted active polysaccharide and application |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022077853A1 true WO2022077853A1 (en) | 2022-04-21 |
Family
ID=74113140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/080132 WO2022077853A1 (en) | 2020-10-15 | 2021-03-11 | Method for extracting grifola frondosa active polysaccharide, and extracted active polysaccharide and use thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112225827A (en) |
WO (1) | WO2022077853A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112225827A (en) * | 2020-10-15 | 2021-01-15 | 广东粤微生物科技有限公司 | Extraction method of active polysaccharide of grifola frondosa, extracted active polysaccharide and application |
CN113968919A (en) * | 2021-11-25 | 2022-01-25 | 浙江百山祖生物科技有限公司 | Edible fungus extract without auxiliary materials and preparation method thereof |
CN114149514B (en) * | 2022-01-05 | 2022-12-06 | 江苏华骏生物科技有限公司 | Extraction method and application of maitake mushroom extract |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101736053A (en) * | 2010-02-01 | 2010-06-16 | 南京泽朗医药科技有限公司 | Technique for extracting Grifola frondosa water-soluble polysaccharide |
CN102408494A (en) * | 2011-11-30 | 2012-04-11 | 杭州众芝康菇生物技术有限公司 | Grifola frondosa polysaccharide ZZK component and preparation method thereof |
CN103724445A (en) * | 2013-12-25 | 2014-04-16 | 广东省微生物研究所 | Preparation method and blood sugar lowering function of Grifola frondosa polysaccharide F2 |
CN104262501A (en) * | 2014-09-30 | 2015-01-07 | 天津生机集团股份有限公司 | Method for extracting grifola frondosa fermentation broth polysaccharide by virtue of dual-membrane process |
JP5882635B2 (en) * | 2011-08-22 | 2016-03-09 | 株式会社雪国まいたけ | Maitake-derived polymeric α-glucan |
CN105732250A (en) * | 2016-02-06 | 2016-07-06 | 福建农林大学 | Preparing method for high-purity grifola frondosa polyphenol component |
CN112225827A (en) * | 2020-10-15 | 2021-01-15 | 广东粤微生物科技有限公司 | Extraction method of active polysaccharide of grifola frondosa, extracted active polysaccharide and application |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102972213B (en) * | 2012-12-31 | 2014-04-09 | 黄河三角洲京博化工研究院有限公司 | Grifola frondosa strain and method utilizing strain for liquid fermentation to cogenerate laccase and beta-glucan |
CN110559332A (en) * | 2019-10-11 | 2019-12-13 | 广东粤微生物科技有限公司 | Ganoderma lucidum and grifola frondosa hypoglycemic composition as well as preparation method and application thereof |
-
2020
- 2020-10-15 CN CN202011101483.6A patent/CN112225827A/en active Pending
-
2021
- 2021-03-11 WO PCT/CN2021/080132 patent/WO2022077853A1/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101736053A (en) * | 2010-02-01 | 2010-06-16 | 南京泽朗医药科技有限公司 | Technique for extracting Grifola frondosa water-soluble polysaccharide |
JP5882635B2 (en) * | 2011-08-22 | 2016-03-09 | 株式会社雪国まいたけ | Maitake-derived polymeric α-glucan |
CN102408494A (en) * | 2011-11-30 | 2012-04-11 | 杭州众芝康菇生物技术有限公司 | Grifola frondosa polysaccharide ZZK component and preparation method thereof |
CN103724445A (en) * | 2013-12-25 | 2014-04-16 | 广东省微生物研究所 | Preparation method and blood sugar lowering function of Grifola frondosa polysaccharide F2 |
CN104262501A (en) * | 2014-09-30 | 2015-01-07 | 天津生机集团股份有限公司 | Method for extracting grifola frondosa fermentation broth polysaccharide by virtue of dual-membrane process |
CN105732250A (en) * | 2016-02-06 | 2016-07-06 | 福建农林大学 | Preparing method for high-purity grifola frondosa polyphenol component |
CN112225827A (en) * | 2020-10-15 | 2021-01-15 | 广东粤微生物科技有限公司 | Extraction method of active polysaccharide of grifola frondosa, extracted active polysaccharide and application |
Also Published As
Publication number | Publication date |
---|---|
CN112225827A (en) | 2021-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022077853A1 (en) | Method for extracting grifola frondosa active polysaccharide, and extracted active polysaccharide and use thereof | |
CN101961371B (en) | Method for extracting and separating ginsenoside, flavone and polysaccharide from sweet gynostemma pentaphylla | |
CN106366136A (en) | Sialic acid, and preparation method and application thereof | |
US10835552B2 (en) | Method for preparing linseed polysaccharide having antiviral activity and immunological activity, and use of the linseed polysaccharide | |
CN102838686B (en) | Method for preparing high-purity agaricus blazei murrill polysaccharide | |
CN108047343B (en) | Preparation method and application of fritillaria pallidiflora total polysaccharide | |
CN109400742B (en) | Dendrobium devonianum refined polysaccharide and preparation method and application thereof | |
CN106279461B (en) | A kind of selenizing maca polysaccharide and its preparation method and application | |
CN104926954A (en) | Method for separating and preparing polysaccharide, oligosaccharide and mannitol from cistanche | |
CN1814166A (en) | Pulse-promoting powder injecta and preparing method | |
CN101084945A (en) | Olive leaves extraction and preparation method thereof | |
CN102108352A (en) | Immobilization method of bromelain | |
WO2021042700A1 (en) | Method for extracting hemp polysaccharides, product obtained thereby and use thereof | |
CN110772630A (en) | Compound bitter gourd peptide oral liquid for activating insulin receptor and regulating blood sugar and preparation method thereof | |
US20220370541A1 (en) | Activated insulin, compound momordica charantia peptide oral medicine for treatment of diabetes, and preparation method | |
CN111248440B (en) | Functional jasmine flower oligosaccharide oral liquid and application thereof | |
US3856945A (en) | Method of reducing serum cholesterol level with extract of konjac mannan | |
CN109806285B (en) | Moringa oleifera leaf extract with uric acid reducing activity and preparation method and application thereof | |
CN101036631A (en) | Ginkgo leaves purified lyophiled powder preparing technique | |
CN113100320B (en) | Walnut oligopeptide candy with function of relieving sub-health fatigue and preparation method thereof | |
CN113307893A (en) | Preparation and purification method of high-purity grifola frondosa polysaccharide extract | |
CN108969580B (en) | Preparation method and application of blue cloth total tannin | |
CN103705907B (en) | Preparation method and application of turtle shell active polypeptide extractive | |
CN113368127A (en) | Selenium polysaccharide and preparation method and application thereof | |
CN113061199A (en) | Process for concentrating and extracting crude heparin sodium by using nanofiltration membrane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21878909 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21878909 Country of ref document: EP Kind code of ref document: A1 |